Meda Pharmaceuticals Inc. v. Perrigo UK FINCO Limited Partnership
1:16-cv-00794
Overview
Parties
Defendant
Perrigo Pharmaceuticals Co. Operating Company
Represented By
2 Attorneys ListedPhillips, Goldman, McLaughlin & Hall, P.A.
Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street
Phillips, McLaughlin & Hall, P.A.
Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St
Perrigo Company NPE (Individual / Inventor)
Represented By
2 Attorneys ListedPhillips, Goldman, McLaughlin & Hall, P.A.
Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street
Phillips, McLaughlin & Hall, P.A.
Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St
Perrigo UK FINCO Limited Partnership NPE (University / Research)
Represented By
3 Attorneys ListedPhillips, Goldman, McLaughlin & Hall, P.A.
Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street
Phillips, McLaughlin & Hall, P.A.
Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St
Plaintiff
Cipla Ltd. Operating Company
Represented By
4 Attorneys ListedAshby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Ashby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Stamoulis & Weinblatt LLC
Stamoulis & Weinblatt LLC, 800 N. West Street, Third Floor
Meda Pharmaceuticals Inc. Operating Company
Represented By
11 Attorneys ListedAshby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Ashby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Stamoulis & Weinblatt LLC
Stamoulis & Weinblatt LLC, 800 N. West Street, Third Floor
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 13 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | Asserted Patent | View Official Patent → |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇬🇧 United Kingdom | United Kingdom Counterpart | View Official Patent → | |
| 🇬🇧 United Kingdom | United Kingdom Counterpart | View Official Patent → | |
| 🌐 PCT International (WIPO) | PCT World Application | View Official Patent → |
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC v. Cipla Limited et al.
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC v. Cipla Limited et al.
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC v. Cipla Limited et al.
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC v. Cipla Limited et al.
Argentum Pharmaceuticals LLC v. Cipla Limited
Patents Involved
There are 3 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US8168620
Combination of azelastine and steroids
|
Filed: 2003-06-13
Issued: 2012-05-01
|
Expired (Term Ended)
+987d PTA
Expires: 2026-02-24
|
|
|
US9259428
Combination of azelastine and fluticasone for nasal administration
|
Filed: 2015-03-18
Issued: 2016-02-16
|
Active (8.3 yrs remaining)
Expires: 2035-03-18
|
|
|
US8163723
Combination of azelastine and steroids
|
Filed: 2010-09-10
Issued: 2012-04-24
|
Expired (Term Ended)
Expires: 2023-08-29
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.
High PTA (+987 days) / In re Cellect scrutiny applies.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
17
Dispositive
0
Granted
0
Denied
0
Pending / Review
9
Motions by Category
Key Dispositive Motions & Rulings